Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71335-3144

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-3144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Atorvastatin Figure1)

This is an evaluation of the effect of Atorvastatin 10 mg/day on the cumulative incidence of non-fatal myocardial infarction or coronary heart disease death as seen in the ASCOT-LLA study. The data presented shows a significant reduction in incidence compared to the placebo group, with a hazard ratio of 0.64 (95% CI 0.50-0.83, p=0.0005) over a period of 3 to 3.5 years.*

FDA Label Image

Figure2 (Atorvastatin Figure2)

The text provides data from a study called CARDS evaluating the effect of Atorvastatin 10 mg/day on the time to occurrence of major cardiovascular events, including myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or stroke. The study compared the outcomes of patients receiving placebo versus Atorvastatin over a four-year follow-up period. Atorvastatin showed a hazard ratio of 0.63 (0.48-0.83) with a p-value of 0.001, indicating a significant reduction in the occurrence of major cardiovascular events compared to placebo.*

FDA Label Image

Figure3 (Atorvastatin Figure3)

This is a comparison of the effect of Atorvastatin at 80 mg/day versus 10 mg/day on the time to occurrence of major cardiovascular events. The data shows a hazard ratio of 0.78 (95% CI 0.69-0.89) with a p-value of 0.0002, indicating a significant difference. The graph displays the time to the first major cardiovascular endpoint in years.*

FDA Label Image

Structure (Atorvastatin Structure)

FDA Label Image

Label (Lbl713353144)

The text appears to be a label for Atorvastatin Calcium Trihydrate tablets containing 10 mg of Atorvastatin. It includes information about storage conditions, dosage instructions, manufacturer details, and a QR code for accessing full prescribing information. The tablets are film-coated and should be kept out of reach of children in tight containers.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.